Antimicrobial Resistance in the bladder.
From our CMO Professor Scott Glickman Colleagues: In medical and surgical services spanning primary through intensive care, we are dogged...
top of page
Search
Gabriel Korn
- Apr 20
- 1 min
UroPharma is moving rapidly to commercialisation. The science and momentum are with us.
We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....
46 views0 comments
Gabriel Korn
- Mar 10
- 1 min
New opportunities in bladder treatments.
As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...
24 views0 comments
Gabriel Korn
- Feb 21
- 1 min
Better bladder treatments in the pipeline
Why would a doctor prefer to prescribe drugs for direct delivery to the bladder over others? For their patients: It is well known amongst...
104 views0 comments
Gabriel Korn
- Feb 7
- 2 min
New Bladder therapies to ease the suffering of millions by simply changing clinical practice.
UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...
30 views0 comments
Gabriel Korn
- Dec 19, 2022
- 1 min
86% nocturia reduction in Direct-to-Bladder clinical trial.
This research by Dr Luna-Rivera is one of many pieces of evidence that Direct-to-Bladder therapies can produce better outcomes than...
29 views0 comments
Gabriel Korn
- Nov 25, 2022
- 1 min
Benefits of Direct-to-Bladder drug targeting.
Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...
9 views0 comments
Gabriel Korn
- Nov 9, 2022
- 1 min
Current bladder therapies is causing harm to millions of people daily
Practitioners and investors please take note. Drugs taken orally to treat common bladder conditions, notably antibiotics and...
11 views0 comments
Gabriel Korn
- Aug 12, 2022
- 1 min
Direct to Bladder Therapies
About UroPharma UroPharma has patented and developed the world’s first licensed ‘direct to bladder’ drug delivery system, that will be in...
19 views0 comments
Gabriel Korn
- Jul 28, 2022
- 1 min
UTI update
Professor Glickman brought our attention to the following article which is very relevant to our R&D efforts and makes for interesting...
11 views0 comments
-
- Jun 21, 2021
- 1 min
New Anglia Local Enterprise Partnership - Certificate of Support
Development of dtb-Instilla Device is supported by the New Anglia Local Enterprise Partnership - Growth Through Innovation Fund This is...
46 views0 comments
-
- Jan 12, 2021
- 1 min
Feasibility study of targeted drug delivery product to the bladder
Developing innovative drug delivery combinations for improved treatments of functional bladder disorders and urinary tract infections....
41 views0 comments
-
- Jan 8, 2021
- 1 min
GMDN Agency welcomes UK-wide Medical Device Information System
From 1st January 2021 all medical devices placed on the market must be registered by their manufacturers with the MHRA as part of a...
16 views0 comments
-
- Dec 16, 2020
- 2 min
MS Patients at Higher Risk of Bladder Cancer, But Not Breast, Colorectal Cancer
Among more than 50,000 Canadians with MS, the rates of breast and colorectal cancers were not increased compared with people without MS....
22 views0 comments
-
- Nov 30, 2020
- 1 min
UK set to approve Pfizer-BioNTech Covid vaccine within days
Rollout of two-shot jab could begin as soon as December 7 The UK is poised to become the first western country to approve a Covid-19...
17 views0 comments
-
- Nov 16, 2020
- 1 min
Covid-19: Normal life back next winter, says vaccine creator
The impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter, one of its...
13 views0 comments
-
- Nov 4, 2020
- 1 min
Claiming Equivalence Under the EU MDR
Claiming equivalence with a device that is already CE marked can help medical device companies save time and money. But scandals with...
34 views0 comments
-
- Oct 30, 2020
- 1 min
NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis
NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for...
14 views1 comment
-
- Oct 26, 2020
- 1 min
Placing medical devices on the UK market after the end of Brexit transition
UKCA mark and Northern Ireland mark (UKNI) Manufacturers who are not supplying the EU/EEA markets might prefer the UK regulatory system...
19 views0 comments
-
- Oct 16, 2020
- 1 min
Test can help urologists rule out bladder cancer in two hours
A test, which uses patented technology to detect MCM5 in urine, could help urologists rule out bladder cancer in as little as two hours....
15 views0 comments
bottom of page